James Healy, Director: Rapport Therapeutics RAPP Buy · Filed 24/06/10

Trade details

Type: Insider buy
Amount: $8,000,013
Shares · price: 470,589 sh · $17.00 a share
Held after: 1,863,327 sh
Stock: Rapport Therapeutics RAPP
Person: James HealyDirector
Trade date: 24/06/10
Filed: 24/06/10
Days to filing: 0 days

First buy since 2023

Insiders buying this week: 1 insiders
Holding change: +33.8%

Rapport Therapeutics trades, last 26 weeks

What else happened in Rapport Therapeutics around then

Filed or reported within 30 days of the trade day · 24/05/11~24/07/10

James Healy's recent trades

James HealyDirector
BuyBioAge Labs
Buy
BioAge Labs
BIOA
$10.6M
588,888 sh
$10.6M
Filed 24/09/27
Traded 24/09/27
James HealyDirector
BuyBioAge Labs
Buy
BioAge Labs
BIOA
$476.9K
26,497 sh
$476.9K
Filed 24/09/27
Traded 24/09/27
James HealyDirector
BuyBioAge Labs
Buy
BioAge Labs
BIOA
$392.7K
21,814 sh
$392.7K
Filed 24/09/27
Traded 24/09/27
James HealyDirector
BuyBioAge Labs
Buy
BioAge Labs
BIOA
$330.4K
18,353 sh
$330.4K
Filed 24/09/27
Traded 24/09/27
James HealyDirector
BuyBioAge Labs
Buy
BioAge Labs
BIOA
$200K
11,113 sh
$200K
Filed 24/09/27
Traded 24/09/27

James Healy, Director — bought $8M of Rapport Therapeutics RAPP · 470,589 sh @ $17.00 | Whalegun